Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Pinatuzumab Biosimilar – Anti-CD22 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Pinatuzumab Biosimilar - Anti-CD22 mAb - Research Grade |
|---|---|
| Source | CAS 1313706-14-7 |
| Species | Humanized |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Pinatuzumab,ACD22-VCMMAE,DCDT2980S,FCU2803,RG-7593,RO5541072-000,CD22,anti-CD22 |
| Reference | PX-TA1316 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Pinatuzumab Biosimilar - Anti-CD22 mAb - Research Grade
General information on Anti-CD22[Homo sapiens] (Pinatuzumab) Monoclonal Antibody
Pinatuzumab is investigated for the treatment of Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma (NHL).
Related products
Antigen
CD223 Recombinant Protein
PX-P4110 500$
Antigen
Interferon-induced transmembrane protein 1(IFITM1)
PX-P4692 250$
Antigen
SIGLEC2 recombinant protein
PX-P5177 392$
Antigen
IGF1R recombinant protein
PX-P5185 500$
Antigen
CD223 / LAG3, C-His, recombinant protein
PX-P5592 500$
Isotype Control
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
PTX17885 215$Contact us
Send us a message from the form below
Reviews
There are no reviews yet.